Variant report
Variant | nsv970356 |
---|---|
Chromosome Location | chr6:153814015-153850061 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000213121 | chromatin interactions |
ENSG00000112031 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs73787554 | chr6:153814140-153814141 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs145171386 | chr6:153814158-153814159 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs373422946 | chr6:153814209-153814210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs200443107 | chr6:153814218-153814219 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs541046064 | chr6:153814256-153814257 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs71567942 | chr6:153814283-153814284 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs562595140 | chr6:153814330-153814331 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs7758065 | chr6:153814347-153814348 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs143884725 | chr6:153814363-153814364 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs201419770 | chr6:153814364-153814365 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs3220923 | chr6:153814366-153814367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs565016058 | chr6:153814374-153814375 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs567870783 | chr6:153814375-153814376 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs3035906 | chr6:153814396-153814397 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs543287245 | chr6:153814404-153814405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs552056179 | chr6:153814432-153814433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs34193157 | chr6:153814465-153814466 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs113396768 | chr6:153814472-153814473 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs556932739 | chr6:153814517-153814518 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs118048358 | chr6:153814518-153814519 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs75339329 | chr6:153814522-153814523 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs549574658 | chr6:153814536-153814537 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs568038483 | chr6:153814558-153814559 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs570844489 | chr6:153814603-153814604 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs9479617 | chr6:153814646-153814647 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs535569671 | chr6:153814666-153814667 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs547065831 | chr6:153814689-153814690 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs565386764 | chr6:153814717-153814718 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs539052340 | chr6:153814726-153814727 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs9479618 | chr6:153814737-153814738 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs149429849 | chr6:153814766-153814767 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs572727821 | chr6:153814768-153814769 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs576702722 | chr6:153814810-153814811 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs575949402 | chr6:153814833-153814834 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs536823854 | chr6:153814845-153814846 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs185477772 | chr6:153814874-153814875 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs574035417 | chr6:153814883-153814884 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs813773 | chr6:153814892-153814893 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs9479619 | chr6:153814897-153814898 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs143899291 | chr6:153814933-153814934 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs74966875 | chr6:153814994-153814995 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs578040551 | chr6:153815023-153815024 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs545433457 | chr6:153815061-153815062 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs148601107 | chr6:153815107-153815108 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs578056471 | chr6:153815110-153815111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs549292439 | chr6:153815125-153815126 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs6906447 | chr6:153815128-153815129 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs142753213 | chr6:153815149-153815150 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs368580833 | chr6:153815166-153815167 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs555261903 | chr6:153815182-153815183 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Autism | 22495311 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ependymoma | 16718352 | CNVD |
Gastric cancer | 17908304 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Developmental delay | 19490664 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Breast cancer | 17850661 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 20556506 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Developmental delay | 21147756 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Melanoma | 17363583 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Developmental delay | 19459884 | CNVD |
Hearing loss | 19459884 | CNVD |
Microcephaly | 19459884 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:153812800-153815000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr6:153813800-153814600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr6:153814000-153814400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
4 | chr6:153814600-153819200 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr6:153819200-153820000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr6:153833000-153833400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr6:153833000-153833400 | Enhancers | Adipose Nuclei | Adipose |
8 | chr6:153833000-153833600 | Enhancers | Dnd41 | blood |
9 | chr6:153842200-153842600 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |